Medical aesthetics lamah chuan hyaluronic acid filler hmanga enkawlna hlawhtlinna hi doctor-te injection technique dik tak aiin a hla hle a ni. He thuziak hian i thuneihna nei resource library nih a tum a ni. Scientifically-a hyaluronic acid chi hrang hrang mamawh dan azirin kan thlan dan tur kan zirchiang ang a, post-injection care guidelines, medical standard sang ber zawm thei tur te kan sawifiah ang a, hyaluronic acid filler dam rei theihna chungchanga zawhna bulpui ber berte kan chhang bawk ang.
Product Selection Principles: Rheological property hmanga thutlukna siamna tur ruahmanna
Preoperative consultation hi hlawhtlinna lungphum a ni. A pawimawh ber chu an tan client-te aesthetic goal nena inmil ber filler product thlan hi a ni. A hmasa berah chuan a taksa thiltihtheihna (physical property) te hi clinical mamawh hrang hrang nena inmil dan hriatthiam a ngai a ni. Hei hi a tel a ni a, safety standards dermal fillers- hei hi product chu indication dik tak atana hman a nih theih nan a ni.
Hyaluronic acid filler thlan danah hian materials science principle zawm tur a ni. Product pakhat rheological property hian a clinical applicability chu direct-in a hril a, chung zingah chuan core parameter pathum: hardness, cohesion leh elasticity te pawh a tel.
-ah hian Guangzhou AOMA Biotechnology Co., LTD. khawvel pum huapa medical aesthetics market-in a mamawh dik tak tihhlawhtlin tumna, strict taka certified product matrix chi hrang hrang kan pe a ni.
High-hardness products hi ruh structure remodeling atan a tha a, chu chu AOMA Volumafill , chu chuan chin filling leh nose bridge shaping te chu a target tha hle.
Hetiang chi product hian contour stability vawng reng turin support nghet tak a neih a ngai a ni.
Medium-hardness products hi soft tissue filling atan a tha a, chu chu AOMA Facefill LD , chu chuan nasolabial folds leh cheek shaping a siam tha thei a ni. A mizia hian shaping force leh tissue compatibility a balance a ngai a ni.
Low-hardness products hi shallow filling atan a tha a, chu chu AOMA Lipfill , lip augmentation leh fine line correction atan hman theih a ni. Chutiang thil siam chuan flexibility leh ductility tha tak a nei tur a ni.
![AOMA dermal filler products hmanga enkawlna hmun hrang hrang tan]( "AOMA dermal filler products for different treatment areas")
Operation hmaa inbuatsaihna leh beisei dan enkawl dan
Product dik tak an hriat hnuah, operation hmaa inbuatsaihna hnuhnung ber chu tihfel a ngai a ni. Intuitive illustration atan tak tak hman gallery hma leh hnua hyaluronic acid fillers hi customer beisei dan enkawl dan tha ber a ni.
Scientific Postoperative Care kalpui dan tur
Injection i tih zawh meuh chuan quality hian post-injection care HA filler i pek direct-in customer satisfaction leh effect durability a hril a ni.
Operation atanga darkar 4 chhungin intermittent cold compress hi hnawih tur a ni. Cold compress tin hi minute 10 aia rei lo tur a ni a, minute 20 inkar a ni tur a ni. Injection na hmuna direct pressure pek loh tur.
Operation hnu darkar 48 chhung chu high-temperature environment kha khauh taka pumpelh tur a ni. Sauna, hot bath leh exercise nasa tak hian thisen kalna a tizau thei a, hei hian fillers te metabolic rate 30% velin a tisang thei a ni. Tin, hmaiah pressure a awm loh nan dinglam mut a tha bawk.
Operation hnu kar hnih chhungin regular assessment mechanism siam tur a ni. Ni 7 leh 14-naah follow-up neih a tha a, standardized photography hmanga effect stability record a tha bawk. Clinical data atanga a lan dan chuan standardized follow-up hian customer satisfaction chu 92% ah a tisang thei a ni.
Effect hun chhung enkawl dan: Clinical data hmanga anticipatory control
Hyaluronic acid fillers hun chhung hi thil tam takin a nghawng a ni. Product metabolic rate hi injection site activity intensity nen a inzawm tha hle. Nasolabial fold area-a retention time average chu zygomatic area-a retention time aiin 25-30% in a tawi zawk a ni.
'Thla 6-a effect' tih hian filler-in visual effect tha ber a vawn reng chhung a kawk a ni. Hetiang dinhmunah hian filler hian a volume hmasa ber 85% vel a vawng reng a, tissue fusion hian a peak a thleng ta a ni. '12-month persistence' tih hian metabolism tawp lamah pawh product quality sang tak takte basic contour support a la vawng reng theih hun lai a kawk a ni.
Clinical study-ah chuan high-cohesion products standardized care nena hman dun hian thla 18 atanga thla 24 chhung chu hnar shaping effect hi a vawng reng thei tih hmuhchhuah a ni. Lip filling, taksa ruh hnathawh fo vang hian thla 6 atanga thla 9 chhung a awm tlangpui.
Tawpna
nen thawkdunin Guangzhou AOMA Biological Technology Co., Ltd professional hriatna leh product quality sang tak takte chu clinical outcome ropui takah chantir rawh
Detailed care manual hi i professional service tihzauh a ni a, professional post-injection care HA filler hi AOMA World atanga scientifically designed HA filler products te nen a inzawm chuan customer te tan solution kimchang tak, rei tak leh him tak i pe ang.
AOMA product matrix hian safety standard sang ber dermal fillers a inpekna leh hyaluronic acid filler dam rei theihna tur a zawnna nen hian i sumdawnna tihhmasawn nana chakna tichaktu chak tak a nih theih dan hriatthiamna thuk tak nei turin kan sawm che a ni.
![AOMA Exhibition thlirletna neih a ni]( "AOMA Exhibition Review")
FAQ
Q1: Engtin nge injection hnua a effect chu naturalness a nih theih nan?
A: Effect naturalness chu product features leh injection site inmil chiah chiah ah a innghat. Lips ang chi dynamic area tan chuan elastic modulus 200Pa aia hniam product thlan a tha a, an deformation capacity hi natural soft tissue nen a inhnaih zawk avangin. Hnar ang chi structural parts tan chuan contour stability a awm theih nan G’ value 500Pa aia tam nei product thlan tur a ni. Clinical data atanga a lan dan chuan he standard hmanga product thlan hian damlo satisfaction chu 94% ah a tisang thei a ni.
Q2: Injection hnuah eng chen nge swelling a awm a, a kaihhnawih tehfungte chu engte nge ni?
A: A swelling degree hi product formula characteristic nen a inzawm tlat a ni. Uniform molecular distribution avang hian single-phase filler-a swelling time chu ni 2.3±0.5 a ni a, hei hi two-phase product aiin a hniam zawk hle a, ni 3.7±0.8 a ni. Low osmotic pressure formula thlan a tha a, hei hian tissue edema chu a tiziaawm thei hle. Operation zawh veleh porous ice compress device hmangin minute 10 chhung vawi khatah darkar 2 chhung darkar 6 chhung hmang la, hei hian a hring degree chu 45% velin a tihhniam thei a ni.
Q3: A nghawng hun chhung nghawngtu thil pawimawh tak takte chu engte nge ni?
A nghawngtu ber chu product characteristic, injection site leh mimal metabolic danglamna te a ni. Highly cross-linked products te hi hnar ah an retention time hi thla 18 atanga thla 24 vel a ni thei a, hmuiah erawh chuan thla 6 atanga thla 9 vel a ni tlangpui thung. Clinical study-ah chuan booster treatment injection hmasa ber atanga thla 6 atanga thla 9 chhunga a effect hun chhung chu metabolism complete hnua re-injection aiin 40% velin a rei zawk tih hmuhchhuah a ni. Non-invasive phototherapy nen a inzawm chuan collagen regeneration a tichak thei a, overall effect pawh a ti rei lehzual thei bawk.
Q4: Postoperative asymmetry hi engtin nge kan hmachhawn ang?
A: Slight asymmetry (≤5%) hi thil awm fo a ni a, a tlangpuiin a hring a reh deuh deuh chuan kar hnih chhungin a mah chauhin a tha chho thin. Ni 14 hnuah pawh asymmetry langsar tak a la awm chuan hyaluronidase hi fine adjustment atan hman theih a ni. Ni 7 atanga ni 14 chhunga fine-tuning dik tak siam awlsam zawk nan injection hmasa berah filler dosage 10% atanga 15% vel dah reng a tha. Statistics atanga a lan dan chuan 3.2% chauh hian enzymatic hydrolysis treatment an mamawh a ni.
Q5: Engtin nge effect hun chhung hi tihpun theih ang?
A: A solution kimchang tak hman a tha: Pakhatnaah chuan, cohesion sang tak nei, a anti-deformation theihna 50% velin a tihpun theih tur product thlang la Pahnihnaah chuan, postoperative care norms khauh taka zawm leh high-temperature environment (> 40°C) pumpelh hian metabolic rate chu 30% velin a tihhniam thei a ni. A tawp berah chuan maintenance plan mumal tak siam a, effect tlahniam hmasa ber (a tlangpuiin thla 6 atanga thla 9)-ah supplementary injection pek a tha. Clinical data atanga a lan dan chuan he plan hian overall effect duration chu 60% atanga 80% thlengin a ti sei thei a ni.
Q6: Engtikah nge enkawl nawn leh hi ngaihtuah tur?
Clinical observation 5,000 atanga chhut chuan a hnuaia indicator te hi a lo awm chuan re-treatment neih a tha: Tissue volume 15%-20% a tlahniam, contour clarity grade khata tlahniam, emaw patient self-assessment satisfaction 80% hnuai lam a tlahniam emaw. Regular maintenance cycle chu hetiang hi a ni: hmui tan thla 6 atanga thla 8, nasolabial fold tan thla 9 atanga thla 12, ruh structure tan thla 12 atanga thla 18. Preventive maintenance hian formulation dosage 35% vel a humhim a, chu chu a absorption kim hnua reconstitution nen khaikhin chuan a ni.
